Form 40FR12B/A Osisko Development Corp.
Tweet
Share
E-mailNews and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
http://archive.fast-edgar.com/20220525/A228A22CZC2589Z2222U2ZO3PN5DZZ22W242 Filed on: May 25, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Osisko Development Announces Annual Grant of Stock Options, Restricted Share Units and Deferred Share Units
- Seagen Announces Results from Pivotal MOUNTAINEER Trial Demonstrating Clinically Meaningful Antitumor Activity of TUKYSA® (tucatinib) in Combination with Trastuzumab in Previously Treated HER2-Positi
- Osisko Development Announces Tintic Project update
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
